SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-048356
Filing Date
2023-04-21
Accepted
2023-04-21 16:00:38
Documents
12
Period of Report
2023-04-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2313396d1_8k.htm   iXBRL 8-K 34418
  Complete submission text file 0001104659-23-048356.txt   210050

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ntra-20230419.xsd EX-101.SCH 3027
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ntra-20230419_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ntra-20230419_pre.xml EX-101.PRE 22591
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2313396d1_8k_htm.xml XML 3605
Mailing Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 650-249-9090
Natera, Inc. (Filer) CIK: 0001604821 (see all company filings)

IRS No.: 010894487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37478 | Film No.: 23836247
SIC: 8071 Services-Medical Laboratories